跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saphrivax-400 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saphrivax-400
Approved
STANDARD
Saphrivax-400
Sai Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
af98656da00b7dea
Company
Sai Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
af98656da00b7dea
Drug Approval Philippines Name
Saphrivax-400
Product Name
Saphrivax-400
Registration Number
DRP-12771
Brand Name
Saphrivax-400
Generic Name
Aciclovir
Dosage Form
Tablet
Dosage Strength
400 mg
Manufacturer
Sai Parenterals Ltd.
Importer
Nelpa Lifesciences Inc.,
Distributor
Nelpa Lifesciences Inc.,
Issuance Date
25 April 2025
Expiry Date
25 April 2030
Pharmacologic Category
Antiviral (Direct Acting Antiviral)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
af98656da00b7dea
Type
Standard
Back to Philippines FDA Approvals